VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Wednesday, January 7, 2026

Stock Comparison

Cochlear Limited vs Pernod Ricard SA

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Cochlear Limited

COH · ASX

Market cap (USD)$17B
Gross margin (TTM)74.5%
Operating margin (TTM)22.7%
Net margin (TTM)16.2%
SectorHealthcare
IndustryMedical - Devices
CountryAU
Data as of2026-01-04
Moat score
81/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Cochlear Limited's moat claims, evidence, and risks.

View COH analysis

Pernod Ricard SA

RI · Euronext Paris

Market cap (USD)$18.3B
Gross margin (TTM)59.8%
Operating margin (TTM)11.5%
Net margin (TTM)13.8%
SectorConsumer
IndustryBeverages - Wineries & Distilleries
CountryFR
Data as of2025-12-29
Moat score
75/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Pernod Ricard SA's moat claims, evidence, and risks.

View RI analysis

Comparison highlights

  • Moat score gap: Cochlear Limited leads (81 / 100 vs 75 / 100 for Pernod Ricard SA).
  • Segment focus: Cochlear Limited has 3 segments (62.4% in Cochlear Implants); Pernod Ricard SA has 3 segments (42.3% in Asia/Rest of the World).
  • Moat breadth: Cochlear Limited has 8 moat types across 3 domains; Pernod Ricard SA has 4 across 2.

Primary market context

Cochlear Limited

Cochlear Implants

Market

Cochlear implant systems (internal implant + external sound processors) for severe-to-profound hearing loss

Geography

Global

Customer

Hospitals/ENT clinics and audiology programs (providers) serving implant candidates/recipients; reimbursed by public/private payers

Role

Medical device OEM / platform owner (implant + processor + fitting software + clinical support)

Revenue share

62.4%

Pernod Ricard SA

Asia/Rest of the World

Market

Premium spirits brand ownership, marketing, and distribution

Geography

Asia-Pacific, Africa, and other emerging markets

Customer

On-trade, off-trade, distributors, and duty-free operators

Role

Brand owner and local-market route-to-market operator

Revenue share

42.3%

Side-by-side metrics

Cochlear Limited
Pernod Ricard SA
Ticker / Exchange
COH - ASX
RI - Euronext Paris
Market cap (USD)
$17B
$18.3B
Gross margin (TTM)
74.5%
59.8%
Operating margin (TTM)
22.7%
11.5%
Net margin (TTM)
16.2%
13.8%
Sector
Healthcare
Consumer
Industry
Medical - Devices
Beverages - Wineries & Distilleries
HQ country
AU
FR
Primary segment
Cochlear Implants
Asia/Rest of the World
Market structure
Oligopoly
Oligopoly
Market share
60%-65% (reported)
n/a
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
81 / 100
75 / 100
Moat domains
Demand, Legal, Supply
Demand, Supply
Last update
2026-01-04
2025-12-29

Moat coverage

Shared moat types

Brand Trust

Cochlear Limited strengths

Compliance AdvantageCapex Knowhow ScaleIP Choke PointService Field NetworkInstalled Base ConsumablesFormat Lock InData Workflow Lockin

Pernod Ricard SA strengths

Scope EconomiesCapacity MoatDistribution Control

Segment mix

Cochlear Limited segments

Full profile >

Cochlear Implants

Oligopoly

62.4%

Services

Monopoly

25.9%

Acoustics

Oligopoly

11.7%

Pernod Ricard SA segments

Full profile >

Europe

Oligopoly

28.9%

Americas

Oligopoly

28.8%

Asia/Rest of the World

Oligopoly

42.3%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.